Financhill
Sell
39

BBIO Quote, Financials, Valuation and Earnings

Last price:
$26.49
Seasonality move :
-20.12%
Day range:
$26.02 - $26.90
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.18x
P/B ratio:
--
Volume:
4M
Avg. volume:
2.5M
1-year change:
-30.64%
Market cap:
$5B
Revenue:
$9.3M
EPS (TTM):
-$2.41

Earnings Data

Next earnings date for BBIO
Feb 21
2025
Most recent earnings per share
-$0.86
Missed by --
(Nov 12/2024)
Consensus Estimate
-$0.86
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BBIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $39.4M -- -- -$1.09 --
11/12/2024 Q3 $3.4M $2.7M -$0.86 -$0.86 --
08/01/2024 Q2 $4.5M $2.2M -$0.39 -$0.94 $0.55
05/02/2024 Q1 $83.8M $211.1M -$0.20 -$0.54 $0.34
02/22/2024 Q4 $3.8M $1.7M -$0.96 -$0.80 -$0.16
11/02/2023 Q3 -- -- -$1.08 -$0.89 -$0.19
08/03/2023 Q2 -- -- -$0.98 -$0.88 -$0.11
05/04/2023 Q1 -- -- -$0.92 -$0.83 -$0.09
02/23/2023 Q4 -- -- -$0.92 -$0.94 $0.02
11/03/2022 Q3 -- -- -$0.93 -$1.01 $0.08
08/04/2022 Q2 -- -- -$0.07 -$0.86 $0.79
05/05/2022 Q1 -- -- -$1.35 -$1.10 -$0.25
02/24/2022 Q4 -- -- -$1.01 -$0.91 -$0.10
11/04/2021 Q3 -- -- -$1.06 -$0.91 -$0.15
08/05/2021 Q2 -- -- -$0.66 -$0.89 $0.23
05/06/2021 Q1 -- -- -$1.18 -$0.75 -$0.43
02/25/2021 Q4 -- -- -$1.01 -$0.86 -$0.15
11/05/2020 Q3 -- -- -$0.98 -$0.89 -$0.09
08/11/2020 Q2 -- -- -$1.03 -$0.73 -$0.30
05/13/2020 Q1 -- -- -$0.78 -$0.70 -$0.08
03/02/2020 Q4 -- -- -$0.62 -$0.63 $0.01
11/07/2019 Q3 -- -- -$0.51 -$0.54 $0.03
08/14/2019 Q2 -- -- -$0.71 -$0.40 -$0.31
03/31/2019 Q1 -- -- -$0.51 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
09/30/2018 Q3 -- -- -$0.34 -- --
06/30/2018 Q2 -- -- -$0.33 -- --
03/31/2018 Q1 -- -- -$0.40 -- --

BridgeBio Pharma Earnings Questions

  • How Much did BridgeBio Pharma Generate in Revenue Last Quarter?

    BridgeBio Pharma reported $2.7M worth of top line sales in its most recent quarter.

  • Did BridgeBio Pharma Beat Earnings Last Quarter?

    BridgeBio Pharma announced earnings per share of -$0.86 which represents a miss of analyst forecast a -$0.86 per share.

  • Is BridgeBio Pharma Profitable?

    BridgeBio Pharma reported $2.1M that represents $0.01 per share over the last quarter.

  • What is the Analyst Consensus for BridgeBio Pharma EPS Next Year?

    BridgeBio Pharma's earnings are forecast to decrease from -$3.95 per share to -$3.26 per share next year representing a decrease of -36.96%.

  • When is BridgeBio Pharma's Earnings Date?

    BridgeBio Pharma's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock